167 related articles for article (PubMed ID: 15884562)
1. [Research progress of the drug-coated stents].
Yin T; Wang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):389-91. PubMed ID: 15884562
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
4. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.
Babapulle MN; Joseph L; Bélisle P; Brophy JM; Eisenberg MJ
Lancet; 2004 Aug 14-20; 364(9434):583-91. PubMed ID: 15313358
[TBL] [Abstract][Full Text] [Related]
5. [Drug-coated stents. Where do we stand in 2004?].
Scheller B
Z Kardiol; 2004 Sep; 93(9):646-8. PubMed ID: 15365731
[No Abstract] [Full Text] [Related]
6. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
7. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents: the panacea for restenosis?
Lim MC
Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
[No Abstract] [Full Text] [Related]
9. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
Lau KW; Johan A; Sigwart U; Hung JS
Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
[TBL] [Abstract][Full Text] [Related]
10. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
Speck U; Scheller B; Rutsch W; Laule M; Stangl V
EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
[TBL] [Abstract][Full Text] [Related]
12. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
13. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
14. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.
Grube E; Buellesfeld L
Expert Rev Med Devices; 2006 Nov; 3(6):731-41. PubMed ID: 17280537
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
17. Are drug-eluting stents a panacea for patients with coronary heart disease?
Schofer J; Schlüter M
Lancet; 2004 Aug 14-20; 364(9434):558-9. PubMed ID: 15313338
[No Abstract] [Full Text] [Related]
18. [Drug eluting stents--end of restenosis?].
Groch L
Vnitr Lek; 2004 Oct; 50 Suppl 1():S59-62. PubMed ID: 15651142
[No Abstract] [Full Text] [Related]
19. [Progress on reasech of drug-coated stent].
Zhang L; Liu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents. The third revolution in percutaneous coronary intervention.
Saia F; Marzocchi A; Serruys PW
Ital Heart J; 2005 Apr; 6(4):289-303. PubMed ID: 15902927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
